Xalatan

Known as: Pfizer brand of latanoprost, Xalatan® 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2017
0519972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
PURPOSE The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first… (More)
Is this relevant?
2008
2008
AIM To compare the conjunctival and corneal reactions of commercially available solution of latanoprost (Xalatan) and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2007
2007
AIM To compare the efficacy and tolerability of Xalatan with generic latanoprost (Latoprost) in subjects with primary open angle… (More)
Is this relevant?
2004
2004
PURPOSE To compare the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure (IOP) in patients with… (More)
Is this relevant?
2004
2004
PURPOSE To report a new adverse effect related to treatment with bimatoprost. CASE REPORTS Serial clinical examination of three… (More)
Is this relevant?
2003
2003
PURPOSE Xalatan treatment has been reported both clinically and experimentally to promote recurrences of herpetic keratitis. Our… (More)
Is this relevant?
2002
2002
PURPOSE To compare, in paired eyes of open-angle glaucoma patients and glaucoma suspects, hydrodynamic and visual changes after 1… (More)
Is this relevant?
2002
2002
BACKGROUND Latanoprost, a prostaglandin F(2alpha)-analogue, has been widely in use in clinical practice for a period of over 5… (More)
Is this relevant?
1998
1998
Latanoprost (PhXA41, Xalatan) and isopropyl unoprostone (UF-021, unoprostone, Rescula) two new prostanoid derivatives, have been… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 1
Is this relevant?